AlphaCrest Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,652
| Closed | -$372K | – | 434 |
|
|
2022
Q3 | $372K | Buy |
+35,652
| New | +$372K | 0.02% | 1078 |
|
|
2022
Q1 | – | Sell |
-16,678
| Closed | -$193K | – | 1302 |
|
|
2021
Q4 | $193K | Sell |
16,678
-52,895
| -76% | -$612K | 0.01% | 1337 |
|
|
2021
Q3 | $664K | Buy |
69,573
+32,212
| +86% | +$307K | 0.03% | 795 |
|
|
2021
Q2 | $360K | Sell |
37,361
-32,678
| -47% | -$315K | 0.02% | 1062 |
|
|
2021
Q1 | $692K | Buy |
70,039
+59,975
| +596% | +$593K | 0.04% | 655 |
|
|
2020
Q4 | $232K | Buy |
+10,064
| New | +$232K | 0.02% | 1015 |
|
|
2020
Q1 | – | Sell |
-22,982
| Closed | -$224K | – | 1104 |
|
|
2019
Q4 | $224K | Buy |
22,982
+4,973
| +28% | +$48.5K | 0.02% | 1177 |
|
|
2019
Q3 | $144K | Buy |
+18,009
| New | +$144K | 0.01% | 1232 |
|